Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07456176 Lipoic acid Pulmonary Disease, Chronic Obstructive Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07456176 clinical trial report covering Lipoic acid, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20260804 Ivonescimab Metastatic Colorectal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20260804 clinical trial report covering Ivonescimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07456033 Depemokimab Asthma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07456033 clinical trial report covering Depemokimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20260822 Tetanus Vaccine,Adsorbed(Beijing Luzhu) Tetanus Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20260822 clinical trial report covering Tetanus Vaccine,Adsorbed(Beijing Luzhu), Phase 3, endpoints, sponsor, geography, readout timing and development
Latest Hotspot
8 min read
NCT07453472 Ademetionine 1,4-Butanedisulfonate Oral Leukoplakia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07453472 clinical trial report covering Ademetionine 1,4-Butanedisulfonate, Phase 3, endpoints, sponsor, geography, readout timing and development white
Latest Hotspot
8 min read
NCT07454707 Clopidogrel Bisulfate Ischemic stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07454707 clinical trial report covering Clopidogrel Bisulfate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07456696 Methylone Stress Disorders, Post-Traumatic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07456696 clinical trial report covering Methylone, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07455383 Alixorexton Narcolepsy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07455383 clinical trial report covering Alixorexton, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07455006 Romiplostim Biosimilar (Qilu Pharma) Purpura, Thrombocytopenic, Idiopathic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07455006 clinical trial report covering Romiplostim Biosimilar (Qilu Pharma), Phase 3, endpoints, sponsor, geography, readout timing and development whi
Latest Hotspot
8 min read
NCT07459296 Sintilimab Nasopharyngeal Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07459296 clinical trial report covering Sintilimab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07453888 Cenegermin-BKBJ Optic Neuropathy, Ischemic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
NCT07453888 clinical trial report covering Cenegermin-BKBJ, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20260588 Recombinant human thyroid stimulating hormone(SmartNuclide) Differentiated Thyroid Gland Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
17 August 2026
CTR20260588 clinical trial report covering Recombinant human thyroid stimulating hormone(SmartNuclide), Phase 3, endpoints, sponsor, geography, readout tim